“In the Alliance A071801 randomized phase 3 trial of 242 patients with resected large brain metastases, three-to-five-session radiosurgery improved one-year surgical-bed control and median survival versus single-session radiosurgery without significant overall adverse-event differences.”

0.9468 under ledger-default@0.3.0 at snapshot 27745.

What was asked, and where it stands. Provisional until audited.

Review 0% done · 0% counted in review coverage (1 claim, 4 checks)

Share:

Checked in Galedra: score 0.95, strongly supported · not yet reviewed by anyone else “In the Alliance A071801 randomized phase 3 trial of 242 patients with resected large brain metastases, three-to-five-session radiosurgery improved one-year surgical-bed control and median survival…” https://galedra.org/investigations/01a0eac9-7a73-7957-b690-018b8014346c

“In the Alliance A071801 randomized phase 3 trial of 242 patients with resected large brain metastases, three-to-five-session radiosurgery improved one-year surgical-bed control and median survival versus single-session radiosurgery without significant overall adverse-event differences.”

Supported · 0.9468 under ledger-default@0.3.0 at snapshot 27745 · review checks 0 of 4 · provisional until audited.

0 of 4 review checks done · 0 counted

See the evidence · Claim card